Ortho-McNeil Sues Barr Over Topamax Generic

Law360, New York (December 18, 2006, 12:00 AM EST) -- A Johnson & Johnson subsidiary has filed a lawsuit against Barr Laboratories Inc. over the company’s move to offer a generic equivalent of lucrative epilepsy and migraine drug Topamax.

Ortho-McNeil Pharmaceutical Inc. alleges in a lawsuit filed Friday in the U.S. District Court for the District of New Jersey that Barr filed an Abbreviated New Drug Application to sell and market the drug before Ortho-McNeil’s patent protection ends in 2008.

Barr also sent a written notice of its ANDA filing to Ortho-McNeil claiming the patent is...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.